These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11124960

  • 21. Role of cysteine residues in the N-terminal extracellular domain of the human VIP 1 receptor for ligand binding. A site-directed mutagenesis study.
    Gaudin P, Couvineau A, Maoret JJ, Rouyer-Fessard C, Laburthe M.
    Ann N Y Acad Sci; 1996 Dec 26; 805():585-9. PubMed ID: 8993444
    [No Abstract] [Full Text] [Related]

  • 22. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
    Juarranz MG, De Neef P, Robberecht P.
    Prostate; 1999 Sep 15; 41(1):1-6. PubMed ID: 10440869
    [Abstract] [Full Text] [Related]

  • 23. Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor.
    Couvineau A, Rouyer-Fessard C, Laburthe M.
    Regul Pept; 2004 Dec 15; 123(1-3):181-5. PubMed ID: 15518910
    [Abstract] [Full Text] [Related]

  • 24. Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
    Nicole P, Du K, Couvineau A, Laburthe M.
    J Pharmacol Exp Ther; 1998 Feb 15; 284(2):744-50. PubMed ID: 9454823
    [Abstract] [Full Text] [Related]

  • 25. Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).
    Knudsen SM, Tams JW, Fahrenkrug J.
    J Mol Neurosci; 2000 Jun 15; 14(3):137-46. PubMed ID: 10984189
    [Abstract] [Full Text] [Related]

  • 26. Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists.
    Langer I, Vertongen P, Perret J, Waelbroeck M, Robberecht P.
    Neuropharmacology; 2003 Jan 15; 44(1):125-31. PubMed ID: 12559130
    [Abstract] [Full Text] [Related]

  • 27. Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.
    Gourlet P, Vilardaga JP, De Neef P, Vandermeers A, Waelbroeck M, Bollen A, Robberecht P.
    Eur J Biochem; 1996 Jul 15; 239(2):349-55. PubMed ID: 8706739
    [Abstract] [Full Text] [Related]

  • 28. Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.
    Laburthe M, Couvineau A.
    Regul Pept; 2002 Oct 15; 108(2-3):165-73. PubMed ID: 12220741
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.
    Ceraudo E, Murail S, Tan YV, Lacapère JJ, Neumann JM, Couvineau A, Laburthe M.
    Mol Endocrinol; 2008 Jan 15; 22(1):147-55. PubMed ID: 17885205
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.
    Langer I, Vertongen P, Perret J, Waelbroeck M, Robberecht P.
    Mol Endocrinol; 2002 May 15; 16(5):1089-96. PubMed ID: 11981043
    [Abstract] [Full Text] [Related]

  • 33. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
    Park CG, Ganguli SC, Pinon DI, Hadac EM, Miller LJ.
    J Pharmacol Exp Ther; 2000 Nov 15; 295(2):682-8. PubMed ID: 11046106
    [Abstract] [Full Text] [Related]

  • 34. Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor.
    Moreno D, Gourlet P, De Neef P, Cnudde J, Waelbroeck M, Robberecht P.
    Peptides; 2000 Oct 15; 21(10):1543-9. PubMed ID: 11068102
    [Abstract] [Full Text] [Related]

  • 35. Localisation of VIP-binding sites exhibiting properties of VPAC receptors in chromaffin cells of rainbow trout (Oncorhynchus mykiss).
    Montpetit CJ, Shahsavarani A, Perry SF.
    J Exp Biol; 2003 Jun 15; 206(Pt 11):1917-27. PubMed ID: 12728013
    [Abstract] [Full Text] [Related]

  • 36. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1996 Dec 15; 50(6):1596-604. PubMed ID: 8967982
    [Abstract] [Full Text] [Related]

  • 37. The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343.
    Gaudin P, Couvineau A, Rouyer-Fessard C, Maoret JJ, Laburthe M.
    Biochem Biophys Res Commun; 1999 Jan 08; 254(1):15-20. PubMed ID: 9920725
    [Abstract] [Full Text] [Related]

  • 38. ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.
    McCulloch DA, Lutz EM, Johnson MS, Robertson DN, MacKenzie CJ, Holland PJ, Mitchell R.
    Mol Pharmacol; 2001 Jun 08; 59(6):1523-32. PubMed ID: 11353814
    [Abstract] [Full Text] [Related]

  • 39. Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation.
    Langer I, Robberecht P.
    Cell Signal; 2005 Jan 08; 17(1):17-24. PubMed ID: 15451021
    [Abstract] [Full Text] [Related]

  • 40. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.
    Langer I, Langlet C, Robberecht P.
    J Mol Endocrinol; 2005 Apr 08; 34(2):405-14. PubMed ID: 15821106
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.